Tofacitinib-Mepha 5 mg
Tofacitinib-Mepha 5 mg is a medicine authorised by Swissmedic under authorisation number 70380. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 August 2026 and the authorisation is limited until 25 August 2031. ATC code L04AF01 places the medicine in the group Immunosuppressants.
| Authorisation number | 70380 |
|---|---|
| Name | Tofacitinib-Mepha 5 mg |
| Full name | Tofacitinib-Mepha 5 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AF01 |
| First authorisation | 26 August 2026 |
| Authorisation validity | 25 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tofacitinib-Mepha 5 mg, Filmtabletten | B | 26 August 2026 |
| 2 | Tofacitinib-Mepha 10 mg, Filmtabletten | B | 26 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L04AF01 | 07.15.0. | B |
| 2 | 56 | Tablette(n) | L04AF01 | 07.15.0. | B |
| 3 | 60 | Tablette(n) | L04AF01 | 07.15.0. | B |
| 4 | 60 | Tablette(n) | L04AF01 | 07.15.0. | B |
| 5 | 56 | Tablette(n) | L04AF01 | 07.15.0. | B |
| 6 | 60 | Tablette(n) | L04AF01 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tofacitinib-Mepha 5 mg authorised in Switzerland?
Yes. Tofacitinib-Mepha 5 mg is authorised by Swissmedic under authorisation number 70380, data as of 01 September 2026. The authorisation is limited until 25 August 2031.
Which dispensing category does Tofacitinib-Mepha 5 mg have?
Tofacitinib-Mepha 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tofacitinib-Mepha 5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.